Following FDA approval of Imaavy, we explore promising biotech candidates in development for myasthenia gravis.

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...

Discover seven lung cancer companies advancing promising candidates through the clinic, from viral immunotherapies to ...

The European Union has launched the Choose Europe for Science initiative and pledged €500 million in funding to attract US ...

Find out if gene therapy has also find its way into skin diseases. With two approvals in the last 2 years, is it the start of ...

Ascentage Pharma is discovering and developing small molecule drugs for the treatment of cancer that block or degrade protein targets implicated in cancer. It has active clinical programs targeting ...

First, let’s take a look at the private biotech investments in March 2025, breaking them down by value, location, funding type, and therapeutic subsector. In March 2025, drug discovery company ...